KREBS BIOCHEMICALS & INDUSTRIES
Back to Income Statement
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹50 Cr | ₹52 Cr | ₹60 Cr | ₹54 Cr | ₹33 Cr |
What is the latest Revenue of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹54 Cr |
| Mar2021 | ₹33 Cr |
How is Revenue of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | -3.28 | |
| Mar2024 | ₹52 Cr | -12.68 | |
| Mar2023 | ₹60 Cr | 11.18 | |
| Mar2022 | ₹54 Cr | 60.72 | |
| Mar2021 | ₹33 Cr | - | |
Compare Revenue of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹149.0 Cr | -1.4% | -2.8% | -15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 2.8% | 6.6% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -0.2% | -0.7% | 10.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | -0.2% | 8.1% | 21.8% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.4% | -1.4% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 2.7% | 1% | -3.4% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -1.4% |
-2.8% |
-15.7% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses